web analytics

Has Acclarent Been Banished from the Ethicon/Johnson & Johnson Empire?

Has Acclarent Been Banished from the Ethicon/Johnson & Johnson Empire?

UPDATED CafePharma Response (below)

August 21, 2014

It’s been shown here time and time again, that when a company does something wrong they will often change their name to distance themselves from unethical or illegal behavior which is a characteristic of The Sociopathic Business Model™.  Once made aware of the characteristics it becomes easier to predict patterns of companies.  As a refresher:

Checklist-of-Characteristic-of-The-Sociopathic-Business-Model (1)On the popular the anonymous message board CafePharma the company Acclarent (a venture capital funded startup sinus device company)  purchased by Johnson & Johnson’s Ethicon in January 2010 for $785 million according to the Wall St. Journal  was, up until last week, under the Ethicon heading on the board made popular by reps and disgruntled former employees.

Acclarent moved out from under Ethicon Johnson & Johnson

Inexplicably the Acclarent board moved out from under Ethicon (a division of Johnson & Johnson)  and under its own company heading.

Acclarent - Cafepharma Message Boards - Google Chrome 8212014 14400 PM

It’s also interesting to note that Acclarent has less than 500 employees but the thread on the board has been viewed more than 353,559 times since the start in 2010. Who could possibly be looking at this company?  What could possibly make this little company that sold for hundreds of millions to the largest producer of consumer and medical products in the World so interesting? Time will tell; and, if fact based evidence over time is any indication of the future The Wall Street Journal will be the only major news outlet covering any story about Johnson & Johnson and their subsidiaries.  I’ll reach out to both CafePharma and the Wall St. Journal for comment.

Cafepharma Response to moving Acclarent board out from under Ethicon

4 Comments
  • Hal Jalikeakik
    Reply

    Acclarent is division of Johnson and Johnson. Acclarent has never been a subdivision of Ethicon (Ethicon Suture, Ethicon Energy, etc). The glib, discontent, and curious may find the Cafe Pharma web blog a barometer of business culture but not comic activity. You seem to be missing that another balloon company is paying millions and millions of dollars each month and year as a royalty. Think Cordis. How many cardiac stent companies also pay millions and millions in royalties to J&J. Jump in for the win. J&J is a “Patent Estate”. A model of success that is in itself an American Treasure. Your choice, be a big fish in your own pond or learn to swim in the deep end of the ocean.
    The strategy is not unique. The execution may be flawed but the cash flow is strong and is simply a license to print money.
    Cafe Pharma is so passed it’s prime. Medtech(y) is the real Blog for MD&D

    August 21, 2014 at 3:53 pm
  • Anonymous
    Reply

    Get a friggin clue. This line of logic demonstrates again why Acclarent was right to fire you. As JS always said “”hireith no assholeith”.

    January 15, 2015 at 7:40 pm

Post a Comment